Bright Minds Applies For Nasdaq Listing
Bright Minds Biosciences (CSE: DRUG) has an eye for the US big boards. The company this morning announced that it
Read moreBright Minds Biosciences (CSE: DRUG) has an eye for the US big boards. The company this morning announced that it
Read moreEight Capital recently produced a primer on the psychedelic sector saying that the companies are “poised to fill a growing
Read moreBright Minds Biosciences Inc. (CSE: DRUG) is a small-cap preclinical biosciences company that is attempting to create the next generation of
Read moreToday on the Daily Dive, our host Cassandra Leah sits down with Ian McDonald, CEO of Bright Minds Biosciences (CSE:
Read moreBright Minds Biosciences (CSE: DRUG) this morning enhanced its leadership team. The company appointed two industry executives to key roles
Read more